Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003365 · ClinicalTrials.gov registry record · NA
Sulindac and Plant Compounds in Preventing Colon Cancer
A NA study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
NCT00003365: Clinical Trial NA study, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00003365 is a NA study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00003365, a NA study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of sulindac may be an effective way to prevent colon cancer. Eating a diet rich in fruits and vegetables appears to reduce the risk of some types of cancer. Curcumin, rutin, and quercetin are compounds found in plants that may prevent the development of colon cancer. PURPOSE: Randomized clinical trial to study the effectiveness of sulindac, curcumin, rutin, and quercetin in preventing colon cancer.
Interventions
- DIETARY_SUPPLEMENT curcumin
- DRUG quercetin
- DRUG sulindac
- DIETARY_SUPPLEMENT rutin
Trial Details
| Field | Value |
|---|---|
| Start Date | 1996-08 |
| Est. Completion | 2006-07 |
| Phase | NA |
Why NCT00003365 stopped before completion
NCT00003365 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 4 interventions - of which curcumin is the first listed.
NCT00003365 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00003365 about?
NCT00003365 is a clinical study titled "Sulindac and Plant Compounds in Preventing Colon Cancer". RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of sulindac may be an effective way to prevent colon cancer. Eating a diet rich in fruits and vegetables appears to reduce the risk of some types of cancer. Curcumin, rut...
What is the current status of trial NCT00003365?
This trial is currently terminated. It is a NA study. The study started on 1996-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00003365?
The interventions under investigation include: curcumin (DIETARY_SUPPLEMENT), quercetin (DRUG), sulindac (DRUG), rutin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00003365?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia